Med. praxi. 2011;8(10):424-427

Depression in the GP's surgery

MUDr.Radim Kubínek
Klinika psychiatrie FN Olomouc

The paper reviews the issue of depression from the perspective of a general practitioner as being a common and serious medical topic,

presents an overview of diagnostic and pharmacotherapeutic strategies and adds some elementary psychotherapeutic issues that should

not be neglected even in the primary care.

Keywords: depression, screening, diagnosis, treatment

Published: October 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kubínek R. Depression in the GP's surgery. Med. praxi. 2011;8(10):424-427.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Smolík P. Duševní a behaviorální poruchy. Průvodce klasifikací. Nástin nosologie. Diagnostika. Praha: Maxdorf, 1996.
    2. Katon W, Schluberg H. Epidemioloogy of depression in primary care. Gen Hosp Psychiatry 1992; 14: 237-247. Go to original source... Go to PubMed...
    3. Coyne JC, Schwenk TL, Fechner-Bates S. Nondetection of depression by primary care physicians reconsidered. Gen Hosp Psychiatry 1995; 17: 3-12. Go to original source... Go to PubMed...
    4. Thase ME, Howland RH, Friedman ES. Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry 1998; 59(Suppl 5): 5-12.
    5. Noyes R Jr, Garvey MJ, Cook BL, Perry PJ. Benzodiazepine withdrawal: a review of the evidence. J Clin Psychiatry 1988; 49(10): 382-389.
    6. Schweizer E, Rickels K. 1266. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand Suppl. 1998; 393: 95-101. Review. Go to original source... Go to PubMed...
    7. Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctôt KL, Liu BA, Shulman KI, Silver IL, Narango CA, Shear NH. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord. 1997; 46(3): 191-217. Go to original source... Go to PubMed...
    8. Glassman AH, Bigger JT. Antidepressants in coronary heart disease: SSRIs reduce depression, but do they save lifes? JAMA 2007; 297: 411-412. Go to original source... Go to PubMed...
    9. Kennedy P, Rogers BA. Anxiety and depression after spinal cord injury: a longitudinal analysis. Arch Phys Med Rehabil. 2000; 81(7): 932-937. Go to original source... Go to PubMed...
    10. Cipriani A, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatement meta-analysis; Lancet 2009, Feb 28; 373(9665); 746-758. Go to original source... Go to PubMed...
    11. Sheehan DV, Nemeroff CB, Thase ME, Entsuah R. EPIC 016 Study Group. Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features. Int Clin Psychopharmacol. 2009; 24(2): 61-86. Go to original source... Go to PubMed...
    12. Keller MB, Hanks DL, Klein DN. Summary of the DSM -IV mood disorder field trial and issue overview. Psychiatr Clin North Am 1996; 19: 1-27. Go to original source... Go to PubMed...
    13. Coryell W, Akiskal HS, Leon AC, Winokur G, Maser JD, Mueller TI, Keller MB. The time course of nonchronic major depressive disorder: uniformity across episodes and samples. Arch Gen Psychiatry 1994; 51: 405-410. Go to original source... Go to PubMed...
    14. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission. Psychol Med 1995; 25: 1171-1180. Go to original source... Go to PubMed...
    15. Bareš M, Novák T. Zvýšení dávky antidepresiva při nedostatečné odpovědi na léčbu; Psychiatrie pro praxi 2010; 11(2): 9-61.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.